Macrophage ATP-Binding Cassette Transporter A1 Overexpression Inhibits Atherosclerotic Lesion Progression in Low-Density Lipoprotein Receptor Knockout Mice
- 1 April 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (4), 929-934
- https://doi.org/10.1161/01.atv.0000208364.22732.16
Abstract
Background— ATP-binding cassette transporter A1 (ABCA1) is a key regulator of cellular cholesterol and phospholipid transport. Previously, we have shown that inactivation of macrophage ABCA1 induces atherosclerosis in low-density lipoprotein receptor knockout (LDLr−/−) mice. However, the possibly beneficial effects of specific upregulation of macrophage ABCA1 on atherogenesis are still unknown. Methods and Results— Chimeras that specifically overexpress ABCA1 in macrophages were generated by transplantation of bone marrow from human ABCA1 bacterial artificial chromosome (BAC) transgenic mice into LDLr−/− mice. Peritoneal macrophages isolated from the ABCA1 BAC → LDLr−/− chimeras exhibited a 60% ( P =0.0006) increase in cholesterol efflux to apolipoprotein AI. To induce atherosclerosis, the mice were fed a Western-type diet containing 0.25% cholesterol and 15% fat for 9, 12, and 15 weeks, allowing analysis of effects on initial lesion development as well as advanced lesions. No significant effect of macrophage ABCA1 overexpression was observed on atherosclerotic lesion size after 9 weeks on the Western-type diet (245±36×10 3 μm 2 in ABCA1 BAC → LDLr−/− mice versus 210±20×10 3 μm 2 in controls). However, after 12 weeks, the mean atherosclerotic lesion area in ABCA1 BAC → LDLr−/− mice remained only 164±15×10 3 μm 2 ( P =0.0008) compared with 513±56×10 3 μm 2 in controls (3.1-fold lower). Also, after 15 weeks on the diet, lesions in mice transplanted with ABCA1 overexpressing bone marrow were still 1.6-fold smaller (393±27×10 3 μm 2 compared with 640±59×10 3 μm 2 in control transplanted mice; P =0.0015). Conclusion— ABCA1 upregulation in macrophages inhibits the progression of atherosclerotic lesions.Keywords
This publication has 29 references indexed in Scilit:
- ABCA1 Expression in Carotid Atherosclerotic PlaquesStroke, 2004
- Antiinflammatory Properties of HDLCirculation Research, 2004
- HDL Cholesterol and Protective Factors in AtherosclerosisCell Metabolism, 2004
- Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1Journal of Lipid Research, 2003
- The Lipidation by Hepatocytes of Human Apolipoprotein A-I Occurs by Both ABCA1-dependent and -independent PathwaysJournal of Biological Chemistry, 2003
- Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrationsJournal of Lipid Research, 2003
- ABCA1-mediated Cholesterol Efflux Is Defective in Free Cholesterol-loaded MacrophagesJournal of Biological Chemistry, 2002
- Progression of AtheromaArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Increased ABCA1 activity protects against atherosclerosisJCI Insight, 2002
- Molecular Cloning of the Human ATP-Binding Cassette Transporter 1 (hABC1): Evidence for Sterol-Dependent Regulation in MacrophagesBiochemical and Biophysical Research Communications, 1999